145 related articles for article (PubMed ID: 12019082)
1. Pharmacology of beta-L-thymidine and beta-L-2'-deoxycytidine in HepG2 cells and primary human hepatocytes: relevance to chemotherapeutic efficacy against hepatitis B virus.
Hernandez-Santiago B; Placidi L; Cretton-Scott E; Faraj A; Bridges EG; Bryant ML; Rodriguez-Orengo J; Imbach JL; Gosselin G; Pierra C; Dukhan D; Sommadossi JP
Antimicrob Agents Chemother; 2002 Jun; 46(6):1728-33. PubMed ID: 12019082
[TBL] [Abstract][Full Text] [Related]
2. Cellular pharmacology of the anti-hepatitis B virus agent beta-L-2',3'-didehydro-2',3'-dideoxy-N4-hydroxycytidine: relevance for activation in HepG2 cells.
Matthes E; Bünger H
Antimicrob Agents Chemother; 2010 Jan; 54(1):341-5. PubMed ID: 19917760
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the effect of phosphorylated metabolites of anti-human immunodeficiency virus and anti-hepatitis B virus pyrimidine analogs on the behavior of human deoxycytidylate deaminase.
Liou JY; Krishnan P; Hsieh CC; Dutschman GE; Cheng YC
Mol Pharmacol; 2003 Jan; 63(1):105-10. PubMed ID: 12488542
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.
Placidi L; Faraj A; Loi AG; Pierra C; Egron D; Cretton-Scott E; Gosseli G; Périgaud C; Martin LT; Schinazi RF; Imbach JL; el Kouni MH; Bryant ML; Sommadossi JP
Antivir Chem Chemother; 2001 Mar; 12(2):99-108. PubMed ID: 11527047
[TBL] [Abstract][Full Text] [Related]
5. Strong and selective inhibitors of hepatitis B virus replication among novel N4-hydroxy- and 5-methyl-beta-L-deoxycytidine analogues.
Matthes E; Funk A; Krahn I; Gaertner K; von Janta-Lipinski M; Lin L; Will H; Sirma H
Antimicrob Agents Chemother; 2007 Jul; 51(7):2523-30. PubMed ID: 17404006
[TBL] [Abstract][Full Text] [Related]
6. Anti-hepatitis B virus activity and metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine.
Zhu YL; Dutschman DE; Liu SH; Bridges EG; Cheng YC
Antimicrob Agents Chemother; 1998 Jul; 42(7):1805-10. PubMed ID: 9661025
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the metabolism of beta-L-(-)-2',3'-dideoxy-3'-thiacytidine by thymidine, fludarabine, and nitrobenzylthioinosine.
Rahn JJ; Kieller DM; Tyrrell DL; Gati WP
Antimicrob Agents Chemother; 1997 May; 41(5):918-23. PubMed ID: 9145844
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the replication of hepatitis B virus in vitro by oxymatrine.
Lin M; Yang LY; Li WY; Peng YP; Zheng JK
J Int Med Res; 2009; 37(5):1411-9. PubMed ID: 19930845
[TBL] [Abstract][Full Text] [Related]
9. Antiviral L-nucleosides specific for hepatitis B virus infection.
Bryant ML; Bridges EG; Placidi L; Faraj A; Loi AG; Pierra C; Dukhan D; Gosselin G; Imbach JL; Hernandez B; Juodawlkis A; Tennant B; Korba B; Cote P; Marion P; Cretton-Scott E; Schinazi RF; Sommadossi JP
Antimicrob Agents Chemother; 2001 Jan; 45(1):229-35. PubMed ID: 11120971
[TBL] [Abstract][Full Text] [Related]
10. Intracellular metabolism of beta-L-2',3'-dideoxyadenosine: relevance to its limited antiviral activity.
Placidi L; Cretton-Scott E; Gosselin G; Pierra C; Schinazi RF; Imbach JL; el Kouni MH; Sommadossi JP
Antimicrob Agents Chemother; 2000 Apr; 44(4):853-8. PubMed ID: 10722481
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of FNC, 2'-deoxy-2'-β-fluoro-4'-azidocytidine, against human and duck HBV replication.
Zheng L; Wang Q; Yang X; Guo X; Chen L; Tao L; Dong L; Li Y; An H; Yu X; Wang Q; Chang J
Antivir Ther; 2012; 17(4):679-87. PubMed ID: 22452880
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the metabolic activation of hepatitis C virus nucleoside inhibitor beta-D-2'-Deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130) and identification of a novel active 5'-triphosphate species.
Ma H; Jiang WR; Robledo N; Leveque V; Ali S; Lara-Jaime T; Masjedizadeh M; Smith DB; Cammack N; Klumpp K; Symons J
J Biol Chem; 2007 Oct; 282(41):29812-20. PubMed ID: 17698842
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus sensitivity to interferon-α in hepatocytes is more associated with cellular interferon response than with viral genotype.
Shen F; Li Y; Wang Y; Sozzi V; Revill PA; Liu J; Gao L; Yang G; Lu M; Sutter K; Dittmer U; Chen J; Yuan Z
Hepatology; 2018 Apr; 67(4):1237-1252. PubMed ID: 29059468
[TBL] [Abstract][Full Text] [Related]
14. Effect of stereoisomerism on the cellular pharmacology of beta-enantiomers of cytidine analogs in Hep-G2 cells.
Martin LT; Faraj A; Schinazi RF; Gosselin G; Mathe C; Imbach JL; Sommadossi JP
Biochem Pharmacol; 1997 Jan; 53(1):75-87. PubMed ID: 8960066
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799
[TBL] [Abstract][Full Text] [Related]
16. Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent.
Chu CK; Boudinot FD; Peek SF; Hong JH; Choi Y; Korba BE; Gerin JL; Cote PJ; Tennant BC; Cheng YC
Antivir Ther; 1998; 3(Suppl 3):113-21. PubMed ID: 10726061
[TBL] [Abstract][Full Text] [Related]
17. Effective metabolism and long intracellular half life of the anti-hepatitis B agent adefovir in hepatic cells.
Ray AS; Vela JE; Olson L; Fridland A
Biochem Pharmacol; 2004 Nov; 68(9):1825-31. PubMed ID: 15450948
[TBL] [Abstract][Full Text] [Related]
18. Anti-HBV specific beta-L-2'-deoxynucleosides.
Bryant ML; Bridges EG; Placidi L; Faraj A; Loi AG; Pierra C; Dukhan D; Gosselin G; Imbach JL; Hernandez B; Juodawlkis A; Tennant B; Korba B; Cote P; Cretton-Scott E; Schinazi RF; Sommadossi JP
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):597-607. PubMed ID: 11563077
[TBL] [Abstract][Full Text] [Related]
19. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.
Delaney WE; Miller TG; Isom HC
Antimicrob Agents Chemother; 1999 Aug; 43(8):2017-26. PubMed ID: 10428929
[TBL] [Abstract][Full Text] [Related]
20. Development of a mass spectrometric screening assay for hepatitis B virus entry inhibitors.
Goh B; Choi J; Kang JA; Park SG; Seo J; Kim TY
J Pharm Biomed Anal; 2020 Jan; 178():112959. PubMed ID: 31722821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]